<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365589">
  <stage>Registered</stage>
  <submitdate>4/03/2014</submitdate>
  <approvaldate>20/03/2014</approvaldate>
  <actrnumber>ACTRN12614000294651</actrnumber>
  <trial_identification>
    <studytitle>Clinical outcome study following Total Hip Replacement using the Paragon femoral stem and Global acetabular cup prostheses </studytitle>
    <scientifictitle>A Multi-centre, Prospective, Consecutive Series, Clinical Outcomes Study to evaluate the safety and performance of the Paragon Hip Stem and Global Acetabular Cup prostheses combination following primary Total Hip Arthroplasty in patients with non-Inflammatory Degenerative Joint Disease</scientifictitle>
    <utrn />
    <trialacronym>PGC-COP13S</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>non-Inflammatory Degenerative Joint Disease</healthcondition>
    <healthcondition>primary Total Hip Arthroplasty</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Osteoarthritis</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>This is a prospective study to evaluate radiological and clinical outcomes in patients who undergo primary total hip replacement surgery, using the Paragon femoral stem and Global acetabular cup.
It follows the investigators standard practice for total hip arthroplasty.  Surgical duration will be the same as for routine total hip replacement surgery.
 
</interventions>
    <comparator>n/a</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Devices</interventioncode>
    <interventioncode>Treatment: Surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Evaluate the safety and performance of the Paragon femoral stem and the Global acetabular cup.  Patient clinical and radiographic outcomes will be analysed through 2 years post surgery.</outcome>
      <timepoint>Pre-operative, 1 week, 6 weeks, 6 months and 2 years</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Patient Quality of Life and clinical and functional evaluation will be measured using the,

Assessment of Quality of Life AQoL 6D - a descriptive system of health-related quality of life statements consisting of six dimensions (Independent Living, Mental Health, Coping, Relationships, Pain, Senses) with variable item numbers and response levels.
Oxford Hip Score - a disease specific assessment that evaluates hip pain, symptoms and related function.
Pain Visual Analogue Scale (VAS) - a simple assessment tool consisting of a horizontal 100 mm line, where the endpoints are labelled no pain, and extreme pain that the patient places a vertical line through the horizontal line to monitor their own perception of their pain and its severity.</outcome>
      <timepoint>Pre-operative, 6 weeks, 6 months and 2 years</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-The individual clinically qualifies for primary total hip arthroplasty surgery.
-The individual is diagnosed with a primary diagnosis of non-Inflammatory Degenerative Joint Disease.
-The individual is physically and mentally willing and able to comply with post-operative scheduled clinical and radiographic evaluations and rehabilitation. </inclusivecriteria>
    <inclusiveminage>21</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>85</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-The individual has an active infection within the affected hip joint.
-The individual has had a previous total hip replacement or hip fusion of the affected hip joint.
-The individual has a neuromuscular or neurosensory deficit which limits the ability to evaluate safety and effectiveness of the device or has a systemic disease that would affect the subject's welfare or overall outcome of the study.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>24/03/2014</anticipatedstartdate>
    <actualstartdate>6/06/2014</actualstartdate>
    <anticipatedenddate />
    <actualenddate>30/03/2016</actualenddate>
    <samplesize>70</samplesize>
    <actualsamplesize>72</actualsamplesize>
    <currentsamplesize />
    <recruitmentstatus>Active, not recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>30/03/2018</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Global Orthopaedic Technology Pty Ltd </primarysponsorname>
    <primarysponsoraddress>Unit 10, 7 Meridian Place
Baulkham Hills, NSW 2153</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Global Orthopaedic Technology Pty Ltd</fundingname>
      <fundingaddress>Unit 10, 7 Meridian Place
Baulkham Hills, NSW 2153</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The Paragon hip stem and the Global acetabular cup non-cemented prostheses will be evaluated following primary total hip replacement surgery.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Nepean Blue Mountains Local health District HREC</ethicname>
      <ethicaddress>Court Building , Ground Floor, PO Box 63, Penrith. NSW 2751</ethicaddress>
      <ethicapprovaldate>11/09/2013</ethicapprovaldate>
      <hrec>HREC/13/NEPEAN/78</hrec>
      <ethicsubmitdate>7/06/2013</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Rami Sorial</name>
      <address>Consulting Rooms
60a Derby Street
Penrith, NSW 2750</address>
      <phone>+61 2 4721 2217</phone>
      <fax />
      <email>pharoah1@bigpond.net.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Lyndon Crossley</name>
      <address>Global Orthopaedic Technology
Unit 10, 7 Meridian Place
Baulkham Hills, NSW 2153</address>
      <phone>+61 2 8887 0115</phone>
      <fax />
      <email>lyndon@globalortho.com.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Lyndon Crossley</name>
      <address>Global Orthopaedic Technology
Unit 10, 7 Meridian Place
Baulkham Hills, NSW 2153</address>
      <phone>+61 2 8887 0115</phone>
      <fax />
      <email>lyndon@globalortho.com.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Lyndon Crossley</name>
      <address>Global Orthopaedic Technology
Unit 10, 7 Meridian Place
Baulkham Hills, NSW 2153</address>
      <phone>+61 2 8887 0115</phone>
      <fax />
      <email>lyndon@globalortho.com.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>